dimethoxyphenylethylamine has been researched along with Chronic Illness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kocić, I; Schetz, A; Schetz, D | 1 |
| Narasimhachari, N | 1 |
| Bergen, JR; Moorman, P; Mulhall, S | 1 |
| Morozov, LT | 1 |
4 other study(ies) available for dimethoxyphenylethylamine and Chronic Illness
| Article | Year |
|---|---|
A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
Topics: Adolescent; Adult; Chronic Disease; Depersonalization; Designer Drugs; Dimethoxyphenylethylamine; Female; Hallucinations; Hallucinogens; Humans; Male; Panic Disorder; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Young Adult | 2022 |
3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Autistic Disorder; Child; Child, Preschool; Chromatography, Gas; Chromatography, Thin Layer; Chronic Disease; Dimethoxyphenylethylamine; Humans; Middle Aged; Phenethylamines; Schizophrenia | 1979 |
Comparison of 3,4-dimethoxyphenylethylamine treated plasma from chronic schizophrenics and controls.
Topics: Amphetamine; Animals; Behavior, Animal; Biogenic Amines; Blood; Brain Chemistry; Chronic Disease; Crowding; Dimethoxyphenylethylamine; Female; Humans; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Phenethylamines; Schizophrenia; Stereotyped Behavior | 1975 |
[Toxicity of a dimethoxyphenylethylamine incubate with the blood plasma of schizophrenia patients].
Topics: Acute Disease; Animals; Chronic Disease; Dimethoxyphenylethylamine; Humans; Iproniazid; Mice; Nialamide; Phenethylamines; Plasma; Schizophrenia; Time Factors | 1974 |